The digital health market surged in the first half of 2025, driven by an influx of nearly $4 billion in venture capital for AI-enabled startups—accounting for 62% of all digital health VC funding. According to Rock Health, total sector funding reached $6.4 billion across 245 deals, with fewer transactions but higher average deal sizes compared to 2024. AI startups, particularly those focusing on clinical and non-clinical workflows and data infrastructure, dominated investment interest. These companies attracted significant capital, averaging $34.4 million per round—an 83% premium over their non-AI peers. Notably, nine of the year’s eleven “mega deals” (over $100 million) were secured by AI-enabled companies, reflecting growing investor confidence and rapid provider adoption, especially in ambient medical documentation tools, which have seen utilization rates as high as 90% in some hospitals.
Among the standout funding rounds, Hippocratic AI secured a $141 million Series B, underscoring its position as a leader in generative AI for healthcare. The company continues to gain traction with its non-diagnostic clinical agents, designed to support overburdened healthcare systems worldwide. CEO Munjal Shah and his team have capitalized on global momentum, expanding internationally and partnering with major organizations like KPMG. Their success reflects a broader market trend in which strategic integration of AI into clinical workflows is becoming essential, not optional. Despite this growth, the sector faces uncertainties tied to economic conditions and federal policies, including potential market contractions from proposed Medicaid and ACA changes. Nonetheless, ongoing M&A activity and public-sector engagement suggest that healthcare AI, led by firms like Hippocratic AI, will continue to shape the digital health landscape.